Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
45,744,125
-
Share change
-
+1,638,280
-
Total reported value
-
$3,883,354,548
-
Put/Call ratio
-
343%
-
Price per share
-
$84.87
-
Number of holders
-
396
-
Value change
-
+$135,883,173
-
Number of buys
-
172
-
Number of sells
-
154
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2017
As of 31 Dec 2017,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
396 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,744,125 shares.
The largest 10 holders included
CITIGROUP INC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, ALLIANCEBERNSTEIN L.P., JPMORGAN CHASE & CO, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
396
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.